Intracellular ferritin accumulation in neural and extraneural tissue characterizes a neurodegenerative disease associated with a mutation in the ferritin light polypeptide gene
- PMID: 15099026
- DOI: 10.1093/jnen/63.4.363
Intracellular ferritin accumulation in neural and extraneural tissue characterizes a neurodegenerative disease associated with a mutation in the ferritin light polypeptide gene
Abstract
Abnormal accumulation of ferritin was found to be associated with an autosomal dominant slowly progressing neurodegenerative disease clinically characterized by tremor, cerebellar ataxia, parkinsonism and pyramidal signs, behavioral disturbances, and cognitive decline. These symptoms may appear sequentially over a period of 4 decades. Pathologically, intranuclear and intracytoplasmic bodies were found in glia and subsets of neurons in the central nervous system as well as in extraneural tissue. Biochemical analyses of these bodies isolated from the striatum and cerebellar cortex revealed that ferritin light polypeptide (FTL) and ferritin heavy polypeptide (FTH1) were the main constituents. Molecular genetic studies revealed a 2-bp insertion mutation in exon 4 of the FTL gene. The resulting mutant polypeptide is predicted to have a carboxy terminus that is altered in amino-acid sequence and length. In tissue sections, the bodies were immunolabeled by anti-ferritin and anti-ubiquitin antibodies and were stained by Perls' method for ferric iron. Synthetic peptides homologous to the altered and wild-type carboxy termini were used to raise polyclonal antibodies. These novel antibodies as well as an antibody recognizing FTH1 immunolabeled the bodies. This study of this disorder has provided additional knowledge and insights in the growing area of ferritin-related neurodegeneration.
Similar articles
-
Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease.Nat Genet. 2001 Aug;28(4):350-4. doi: 10.1038/ng571. Nat Genet. 2001. PMID: 11438811
-
Expression of a mutant form of the ferritin light chain gene induces neurodegeneration and iron overload in transgenic mice.J Neurosci. 2008 Jan 2;28(1):60-7. doi: 10.1523/JNEUROSCI.3962-07.2008. J Neurosci. 2008. PMID: 18171923 Free PMC article.
-
Iron loading-induced aggregation and reduction of iron incorporation in heteropolymeric ferritin containing a mutant light chain that causes neurodegeneration.Biochim Biophys Acta. 2011 Apr;1812(4):544-8. doi: 10.1016/j.bbadis.2010.10.010. Epub 2010 Oct 26. Biochim Biophys Acta. 2011. PMID: 21029774 Free PMC article.
-
Neuroferritinopathy: a neurodegenerative disorder associated with L-ferritin mutation.Best Pract Res Clin Haematol. 2005 Jun;18(2):265-76. doi: 10.1016/j.beha.2004.08.021. Best Pract Res Clin Haematol. 2005. PMID: 15737889 Review.
-
New Insights into the Role of Ferritin in Iron Homeostasis and Neurodegenerative Diseases.Mol Neurobiol. 2021 Jun;58(6):2812-2823. doi: 10.1007/s12035-020-02277-7. Epub 2021 Jan 28. Mol Neurobiol. 2021. PMID: 33507490 Review.
Cited by
-
Cortical pencil lining in neuroferritinopathy: a diagnostic clue.Neurology. 2015 Apr 28;84(17):1816-8. doi: 10.1212/WNL.0000000000001511. Epub 2015 Apr 1. Neurology. 2015. PMID: 25832658 Free PMC article. No abstract available.
-
Brain, blood, and iron: perspectives on the roles of erythrocytes and iron in neurodegeneration.Neurobiol Dis. 2012 Jun;46(3):607-24. doi: 10.1016/j.nbd.2012.03.006. Epub 2012 Mar 9. Neurobiol Dis. 2012. PMID: 22426390 Free PMC article. Review.
-
Clinical features and natural history of neuroferritinopathy caused by the 458dupA FTL mutation.Brain. 2009 Jun;132(Pt 6):e109. doi: 10.1093/brain/awn274. Epub 2008 Oct 14. Brain. 2009. PMID: 18854324 Free PMC article. No abstract available.
-
Progressive brain iron accumulation in neuroferritinopathy measured by the thalamic T2* relaxation rate.AJNR Am J Neuroradiol. 2012 Oct;33(9):1810-3. doi: 10.3174/ajnr.A3036. Epub 2012 Apr 12. AJNR Am J Neuroradiol. 2012. PMID: 22499840 Free PMC article.
-
Behavioral characterization of mouse models of neuroferritinopathy.PLoS One. 2015 Feb 17;10(2):e0118990. doi: 10.1371/journal.pone.0118990. eCollection 2015. PLoS One. 2015. PMID: 25689865 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous